Almitan 6.25 mg Tablet

About Almitan 6.25 mg Tablet

Almitan 6.25 mg comes as a tablet with 6.25 mg of Almotriptan, from Opsonin Pharma Limited. Almotriptan is prescribed to treat the acute headache phase of migraine attacks with or without aura.

What is Almitan 6.25 mg Tablet?

The tablet Almitan 6.25 mg contains Almotriptan and is made by Opsonin Pharma Limited. It has a limited effect on arteries supplying blood to the brain and little effect on cardiac and pulmonary vessels. Almotriptan binds to specific serotonin receptors on meningeal arteries inhibiting the release of vasoactive peptides and causing constriction of the arteries. Ask your doctor or pharmacist if you are unsure about it.

Uses of Almitan 6.25 mg

Almotriptan is prescribed to treat the acute headache phase of migraine attacks with or without aura. Your doctor will decide if it is suitable for you.

How to use Almitan 6.25 mg

Swallow the tablet with water. Almitan 6.25 mg is taken by mouth. If you miss a dose, ask your doctor or pharmacist what to do. Complete the course exactly as prescribed.

Side effects of Almitan 6.25 mg

Serious cardiac reactions, including myocardial infarction, have occurred following the use of Almotriptan malate Tablets. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

There is no data regarding excretion of Almotriptan in human milk. Hypersensitivity to the active substance or to any of the excipients. Patients with severe hepatic impairment, with a previous cerebrovascular accident (CVA) or transient ischaemic attack (TIA) Peripheral vascular disease. Tell your doctor about all the other medicines you take.

Frequently asked questions

Why is Almitan 6.25 mg prescribed?

Almotriptan is prescribed to treat the acute headache phase of migraine attacks with or without aura. Your doctor will decide if it is suitable for you.

How is Almitan 6.25 mg used?

Swallow the tablet with water. Almitan 6.25 mg is taken by mouth.

Can Almitan 6.25 mg cause side effects?

Serious cardiac reactions, including myocardial infarction, have occurred following the use of Almotriptan malate Tablets. Tell your doctor if any side effect bothers you or does not go away.

Is Almitan 6.25 mg safe for everyone?

There is no data regarding excretion of Almotriptan in human milk. Hypersensitivity to the active substance or to any of the excipients.

Indications

Almotriptan is prescribed to treat the acute headache phase of migraine attacks with or without aura. Almotriptan is the only oral triptan approved in the USA for the treatment of migraine in adolescent from 12 to 17 years of age.

Pharmacology

Almotriptan is a selective and potent serotonin (5-hydroxytryptamine 1B/1D) agonist. Almotriptan binds to specific serotonin receptors on meningeal arteries inhibiting the release of vasoactive peptides and causing constriction of the arteries. It has a limited effect on arteries supplying blood to the brain and little effect on cardiac and pulmonary vessels.

Dosage & Administration

Acute Treatment of Migraine Attacks: The recommended dose of Almotriptan in adults and adolescents age 12 to 17 years is 6.25 mg to 12.5 mg, with the 12.5 mg dose tending to be a more effective dose in adults. If the headache is relieved after the initial almotriptan malate dose but returns, the dose may be repeated after 2 hours. The maximum daily dose should not exceed 25 mg. The safety of treating an average of more than four migraines in a 30-day period has not been established.

Hepatic Impairment: The recommended starting dose of almotriptan malate in patients with hepatic impairment is 6.25 mg. The maximum daily dose should not exceed 12.5 mg over a 24-hour period

Renal Impairment: The recommended starting dose of almotriptan malate in patients with severe renal impairment is 6.25 mg. The maximum daily dose should not exceed 12.5 mg over a 24-hour period

Interaction

These drugs have been reported to cause prolonged vasospastic reactions. Cases of life-threatening serotonin syndrome have been reported during combined use of triptans and selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs).

Contraindications

As with other 5-HT1B/1D receptor agonists, almotriptan should not be used in patients with a history, symptoms or signs of ischaemic heart disease (myocardial infarction, angina pectoris, documented silent ischaemia, Prinzmetal's angina) or severe hypertension and uncontrolled mild or moderate hypertension. Concomitant administration with ergotamine, ergotamine derivatives (including methysergide) and other 5-HT1B/1D agonists is contraindicated.

Side Effects

Serious cardiac reactions, including myocardial infarction, have occurred following the use of almotriptan malate Tablets. These reactions are extremely rare and most have been reported in patients with risk factors predictive of CAD (Coronary Artery Disease).

Pregnancy & Lactation

Pregnancy Category C. There is no data regarding excretion of almotriptan in human milk.

Precautions & Warnings

Hypersensitivity to the active substance or to any of the excipients. Patients with severe hepatic impairment, with a previous cerebrovascular accident (CVA) or transient ischaemic attack (TIA) Peripheral vascular disease.

Storage Conditions

Keep below 30° C temperature in a dry place. Protected from light. Do not freeze. Keep out of the reach of children.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.